Attenuation of cocaine-induced conditioned place preference by Polygala tenuifolia root extract

Life Sci. 2004 Oct 22;75(23):2751-64. doi: 10.1016/j.lfs.2004.04.045.

Abstract

A recent investigation indicated that Polygala tenuifolia Willdenow extract (PTE) possesses a potential antipsychotic effect. In this study, we examined the effects of PTE on the cocaine-induced changes in locomotor activity, conditioned place preference (CPP), fos-related antigen-immunoreactivity (FRA-IR), and activator protein (AP)-1 DNA binding activity. Cocaine-induced behavioral effects (hyperlocomotion and CPP) occurred in parallel with increases in FRA-IR and AP-1 DNA binding activity in the nucleus accumbens. These responses induced by cocaine were consistently attenuated by concurrent treatment with PTE (25 mg or 50 mg/kg/day, i.p. x 7). The adenosine A2A receptor antagonist, 1,3,7-trimethyl-8-(3-chlorostyrl)xanthine (0.5 or 1.0 mg/kg, i.p.), reversed the PTE-mediated pharmacological action in a dose related manner; neither the adenosine A(1) receptor antagonist, 8-cyclopentyl-1,3-dimethylxanthine (0.5 or 1.0 mg/kg, i.p.) nor the A2B receptor antagonist, alloxazine (1.5 or 3.0 mg/kg, i.p.) significantly affected this pharmacological action. Our results suggest that PTE prevents cocaine-induced behavioral effects, at least in part, via the activation of the adenosine A2A receptor.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Autoradiography
  • Cocaine / antagonists & inhibitors*
  • DNA / metabolism
  • Immunohistochemistry
  • Locomotion / drug effects*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nucleus Accumbens / immunology
  • Plant Extracts / pharmacology
  • Plant Roots / chemistry*
  • Polygala / chemistry*
  • Proto-Oncogene Proteins c-fos / immunology
  • Purinergic P1 Receptor Antagonists
  • Spatial Behavior / drug effects*
  • Transcription Factor AP-1 / metabolism

Substances

  • Plant Extracts
  • Proto-Oncogene Proteins c-fos
  • Purinergic P1 Receptor Antagonists
  • Transcription Factor AP-1
  • DNA
  • Cocaine